STYLE 410 SIZER 20-MM115-245

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2018-04-03 for STYLE 410 SIZER 20-MM115-245 manufactured by Allergan (costa Rica).

Event Text Entries

[104182749] The event of 'capsular contracture (baker grade iii)' is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event. Additional data: additional information regarding the event, product, or patient details has been requested of the reporter by allergan; no additional information is available at this time. A review of the device history record has been completed. No deviations or non-conformances noted. Device labeling: temporary device: natrelle? Re-sterilizable sizers are temporary devices, and are not intended to be used as a permanent implant. They should only be used for temporary intra-operative placement, to assist the surgeon in permanent implant size selection.
Patient Sequence No: 1, Text Type: N, H10


[104182750] Physician reported left side capsular contracture, baker grade iii. Patient was implanted with a re-sterilizable sizer.
Patient Sequence No: 1, Text Type: D, B5


[116457372] Device evaluation: visual analysis of the returned device identified: deformation, weight to the spec, yellow particle, cloudy, and voids were observed after autoclave disinfection process. Based on the device analysis the final assessment is: no issues found related with the manufacturing process. Device labeling: potential adverse events that may occur with silicone gel-filled breast implant surgery include: implant rupture, capsular contracture, reoperation, implant removal, pain, changes in nipple and breast sensation, infection, scarring, asymmetry, wrinkling, implant displacement/migration, implant palpability/visibility, breastfeeding complications, hematoma/seroma, implant extrusion, necrosis, delayed wound healing, breast tissue atrophy/chest wall deformity, calcium deposits, and lymphadenopathy. Capsular contracture: patients should be advised that capsular contracture may be more common following infection, hematoma, and seroma, and the chance of it happening may increase over time. Capsular contracture occurs more commonly in revision patients than in primary augmentation or reconstruction patients. Capsular contracture is also a risk factor for implant rupture, and it is one of the most common reasons for reoperation.
Patient Sequence No: 1, Text Type: N, H10


[116457373] Health professional reported left side capsular contracture, baker grade iii. Device has been explanted.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9617229-2018-02045
MDR Report Key7392490
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2018-04-03
Date of Report2018-05-04
Date Mfgr Received2018-04-10
Device Manufacturer Date2002-01-19
Date Added to Maude2018-04-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. SUZANNE WOJCIK
Manufacturer Street301 W HOWARD LANE SUITE 100
Manufacturer CityAUSTIN TX 78753
Manufacturer CountryUS
Manufacturer Postal78753
Manufacturer Phone7372473605
Manufacturer G1ALLERGAN (COSTA RICA)
Manufacturer Street900 PARKWAY GLOBAL PARK ZONA FRANCA
Manufacturer CountryCS
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSTYLE 410 SIZER
Generic NameSIZER, MAMMARY, BREAST IMPLANT VOLUME
Product CodeMRD
Date Received2018-04-03
Catalog Number20-MM115-245
Lot Number132100
Device Expiration Date2007-01-15
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerALLERGAN (COSTA RICA)
Manufacturer Address900 PARKWAY GLOBAL PARK ZONA FRANCA CS


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2018-04-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.